|
|
Blood, 1 December 2003, Vol. 102, No. 12, pp. 4084-4089.
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-02-0518.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment
Deniz Durali,
Marie-Ghislaine de Goër de Herve,
Julien Giron-Michel,
Bruno Azzarone,
Jean-François Delfraissy, and
Yassine Taoufik
From INSERM E-109, Université Paris-XI, Bicêtre, INSERM U-542, Villejuif, France; and Department of Biology, University of Quebec at Montreal (UQAM), Montreal, QE, Canada.
Two functionally distinct subsets of B cells that produce Th1- and Th2-like patterns of cytokines have recently been identified. Interleukin-12 (IL-12) is a critical immunoregulatory cytokine that promotes Th1 differentiation through activation of signal transducer and activator of transcription 4 (STAT4). IL-12 has been reported to induce interferon (IFN- ) production in B cells, but the relevant signaling pathways are poorly documented. Here, in human primary B cells, we found a functional IL-12 receptor (IL-12R) that internalizes following IL-12 binding. IFN- and, to a lesser extent, IL-12 positively regulated the IL-12R 2 subunit but had no effect on IL-12R 1. On examining the effect of IL-12 on STAT4 and T-bet (2 key factors involved in IFN- promoter activation), we found that IL-12 induced the phosphorylation and nuclear translocation of STAT4. IL-12-dependent constitutive STAT4 activation was also observed in the Epstein-Barr virus (EBV)-transformed B-cell line RPMI 8866 that spontaneously produces IL-12. T-bet expression has been shown to be dependent on STAT1. IL-12 had no direct effect on STAT1 activation or T-bet expression in primary B cells. In contrast, IL-12-induced IFN- led to STAT1 activation, strong expression of T-bet, and IFN- expression. IL-12 therefore initiates a cascade of events in B cells, including STAT4 activation, IL-12R 2 up-regulation, IFN- production, and T-bet up-regulation, potentially leading to Th1-like differentiation. (Blood. 2003;102:4084-4089)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Ogawa, M. Funaba, and M. Tsujimoto
A dual role of activin A in regulating immunoglobulin production of B cells
J. Leukoc. Biol.,
June 1, 2008;
83(6):
1451 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. S. Phoon, A. R. Kitching, D. Odobasic, L. K. Jones, T. J. Semple, and S. R. Holdsworth
T-bet Deficiency Attenuates Renal Injury in Experimental Crescentic Glomerulonephritis
J. Am. Soc. Nephrol.,
March 1, 2008;
19(3):
477 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Atayar, A. van den Berg, T. Blokzijl, M. Boot, R. D Gascoyne, L. Visser, and S. Poppema
Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments
J. Clin. Pathol.,
October 1, 2007;
60(10):
1092 - 1097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Airoldi, C. Cocco, E. Di Carlo, S. Disaro, E. Ognio, G. Basso, and V. Pistoia
Methylation of the IL-12R{beta}2 Gene as Novel Tumor Escape Mechanism for Pediatric B-Acute Lymphoblastic Leukemia Cells.
Cancer Res.,
April 15, 2006;
66(8):
3978 - 3980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Vermi, F. Facchetti, E. Riboldi, H. Heine, S. Scutera, S. Stornello, D. Ravarino, P. Cappello, M. Giovarelli, R. Badolato, et al.
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma
Blood,
January 15, 2006;
107(2):
454 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Harris, S. Goodrich, A. J. Gerth, S. L. Peng, and F. E. Lund
Regulation of IFN-{gamma} Production by B Effector 1 Cells: Essential Roles for T-bet and the IFN-{gamma} Receptor
J. Immunol.,
June 1, 2005;
174(11):
6781 - 6790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M.L. van Herpen, J. A.W.M. van der Laak, I. J. M. de Vries, J. H. van Krieken, P. C. de Wilde, M. G.J. Balvers, G. J. Adema, and P. H.M. De Mulder
Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor
Clin. Cancer Res.,
March 1, 2005;
11(5):
1899 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Atayar, S. Poppema, T. Blokzijl, G. Harms, M. Boot, and A. van den Berg
Expression of the T-Cell Transcription Factors, GATA-3 and T-bet, in the Neoplastic Cells of Hodgkin Lymphomas
Am. J. Pathol.,
January 1, 2005;
166(1):
127 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Torpey, S. E. Maher, A. L. M. Bothwell, and J. S. Pober
Interferon {alpha} but Not Interleukin 12 Activates STAT4 Signaling in Human Vascular Endothelial Cells
J. Biol. Chem.,
June 18, 2004;
279(25):
26789 - 26796.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |